Deficient Liver Biosynthesis of Docosahexaenoic Acid Correlates with Cognitive Impairment in Alzheimer's Disease

Reduced brain levels of docosahexaenoic acid (C22:6n-3), a neurotrophic and neuroprotective fatty acid, may contribute to cognitive decline in Alzheimer's disease. Here, we investigated whether the liver enzyme system that provides docosahexaenoic acid to the brain is dysfunctional in this disease. Docosahexaenoic acid levels were reduced in temporal cortex, mid-frontal cortex and cerebellum of subjects with Alzheimer's disease, compared to control subjects (P = 0.007). Mini Mental State Examination (MMSE) scores positively correlated with docosahexaenoic/α-linolenic ratios in temporal cortex (P = 0.005) and mid-frontal cortex (P = 0.018), but not cerebellum. Similarly, liver docosahexaenoic acid content was lower in Alzheimer's disease patients than control subjects (P = 0.011). Liver docosahexaenoic/α-linolenic ratios correlated positively with MMSE scores (r = 0.78; P<0.0001), and negatively with global deterioration scale grades (P = 0.013). Docosahexaenoic acid precursors, including tetracosahexaenoic acid (C24:6n-3), were elevated in liver of Alzheimer's disease patients (P = 0.041), whereas expression of peroxisomal d-bifunctional protein, which catalyzes the conversion of tetracosahexaenoic acid into docosahexaenoic acid, was reduced (P = 0.048). Other genes involved in docosahexaenoic acid metabolism were not affected. The results indicate that a deficit in d-bifunctional protein activity impairs docosahexaenoic acid biosynthesis in liver of Alzheimer's disease patients, lessening the flux of this neuroprotective fatty acid to the brain.

[1]  Manuela Martínez.  Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders , 1992, Brain Research.

[2]  P. Barberger-Gateau,et al.  Fish, docosahexaenoic acid and Alzheimer's disease. , 2009, Progress in lipid research.

[3]  Y. Yılmaz,et al.  Liver disease as a risk factor for cognitive decline and dementia: An Under‐recognized issue , 2009, Hepatology.

[4]  R. Bazinet,et al.  Fat Intake and CNS Functioning: Ageing and Disease , 2009, Annals of Nutrition and Metabolism.

[5]  N. Bazan,et al.  Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. A. Spector,et al.  Docosahexaenoic acid synthesis in human skin fibroblasts involves peroxisomal retroconversion of tetracosahexaenoic acid. , 1995, Journal of lipid research.

[7]  Kim N. Green,et al.  Intracellular amyloid-β in Alzheimer's disease , 2007, Nature Reviews Neuroscience.

[8]  N. Bazan.  Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors , 2006, Trends in Neurosciences.

[9]  F. LaFerla,et al.  Intracellular amyloid-beta in Alzheimer's disease. , 2007, Nature reviews. Neuroscience.

[10]  S. Rapoport,et al.  Can the rat liver maintain normal brain DHA metabolism in the absence of dietary DHA? , 2009, Prostaglandins, leukotrienes, and essential fatty acids.

[11]  T. Hashimoto,et al.  Physiological role of D-3-hydroxyacyl-CoA dehydratase/D-3-hydroxyacyl-CoA dehydrogenase bifunctional protein. , 1997, Journal of biochemistry.

[12]  Harvey F Lodish,et al.  Docosahexaenoic acid, fatty acid-interacting proteins, and neuronal function: breastmilk and fish are good for you. , 2005, Annual review of cell and developmental biology.

[13]  P. Mukherjee,et al.  Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. L. Haining,et al.  Catalase turnover in rat liver and kidney as a function of age. , 1973, Experimental gerontology.

[15]  Xianlin Han,et al.  Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry , 2001, Journal of neurochemistry.

[16]  M. Morris.  Docosahexaenoic acid and Alzheimer disease. , 2006, Archives of neurology.

[17]  M. Badr,et al.  Biology of senescent liver peroxisomes: role in hepatocellular aging and disease. , 1999, Environmental health perspectives.

[18]  S. Rapoport,et al.  Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.

[19]  B. Brooksbank,et al.  Lipid abnormalities in the brain in adult Down's syndrome and Alzheimer's disease. , 1989, Molecular and chemical neuropathology.

[20]  Charles N Serhan,et al.  A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. , 2005, The Journal of clinical investigation.

[21]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[22]  Frank M LaFerla,et al.  Dietary Docosahexaenoic Acid and Docosapentaenoic Acid Ameliorate Amyloid-β and Tau Pathology via a Mechanism Involving Presenilin 1 Levels , 2007, The Journal of Neuroscience.

[23]  J. Besson,et al.  Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer's disease patients and its relationship to acetyl CoA content. , 1998, The international journal of biochemistry & cell biology.

[24]  Seth Love,et al.  Fatty Acid Composition of Frontal, Temporal and Parietal Neocortex in the Normal Human Brain and in Alzheimer’s Disease , 2010, Neurochemical Research.

[25]  S. Innis.  Dietary omega 3 fatty acids and the developing brain , 2008, Brain Research.

[26]  N. Bazan,et al.  Docosahexaenoic acid and the aging brain. , 2008, The Journal of nutrition.

[27]  R. Wurtman,et al.  Nutrition and the brain. , 1990, Scientific American.

[28]  Takashi Morihara,et al.  Docosahexaenoic Acid Protects from Dendritic Pathology in an Alzheimer's Disease Mouse Model , 2004, Neuron.

[29]  B. S. Mohammed,et al.  Reevaluation of the pathways for the biosynthesis of polyunsaturated fatty acids. , 1995, Journal of lipid research.

[30]  Manuela Martínez.  Severe deficiency of docosahexaenoic acid in peroxisomal disorders , 1990, Neurology.

[31]  Neil Mann,et al.  Origins and evolution of the Western diet: health implications for the 21st century. , 2005, The American journal of clinical nutrition.

[32]  Takashi Morihara,et al.  A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model , 2005, The Journal of Neuroscience.

[33]  P. Lantos,et al.  Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.

[34]  Kevin F Krenitsky,et al.  Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia Published, JLR Papers in Press, August 2, 2007. , 2007, Journal of Lipid Research.

[35]  W. Markesbery,et al.  Regional Membrane Phospholipid Alterations in Alzheimer's Disease , 2004, Neurochemical Research.

[36]  H. Moser,et al.  Peroxisomal straight-chain Acyl-CoA oxidase and D-bifunctional protein are essential for the retroconversion step in docosahexaenoic acid synthesis. , 2001, The Journal of biological chemistry.

[37]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[38]  S. Rapoport,et al.  Quantitative contributions of diet and liver synthesis to docosahexaenoic acid homeostasis. , 2010, Prostaglandins, leukotrienes, and essential fatty acids.

[39]  H. Sprecher,et al.  The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase. , 1991, The Journal of biological chemistry.

[40]  K. Kristensson,et al.  Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease , 1991, Lipids.

[41]  P. Calder,et al.  Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. , 2005, Reproduction, nutrition, development.

[42]  N. Bazan,et al.  Decreased content of docosahexaenoate and arachidonate in plasma phospholipids in Usher's syndrome. , 1986, Biochemical and biophysical research communications.

[43]  J. Besson,et al.  Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects. , 1993, Brain : a journal of neurology.

[44]  H. White.  A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity , 1980 .